BioScale wins funding to develop protein analytics tech
BioScale has secured $25m (€21m) to fund commercialisation of its ViBE protein analytics systems.
BioScale has secured $25m (€21m) to fund commercialisation of its ViBE protein analytics systems.
Pall and New Brunswick have teamed up to develop and supply new disposable bioreactor technologies, targeting growing demand for products that improve quality and reduce cost of biomanufacturing.